Ringer's acetate better for patients with severe sepsis

June 28, 2012
Ringer's acetate better for patients with severe sepsis
Fluid resuscitation with hydroxyethyl starch 130/0.4 for patients with severe sepsis leads to an increased risk of death at day 90 and an increased likelihood of requiring renal-replacement therapy, compared with Ringer's acetate, according to a study published online June 27 in the New England Journal of Medicine.

(HealthDay) -- Fluid resuscitation with hydroxyethyl starch (HES) 130/0.4 for patients with severe sepsis leads to an increased risk of death at day 90 and an increased likelihood of requiring renal-replacement therapy, compared with Ringer's acetate, according to a study published online June 27 in the New England Journal of Medicine.

Anders Perner, M.D., Ph.D., from Rigshospitalet in Copenhagen, Denmark, and colleagues randomly assigned 798 participants with severe sepsis participating in a multicenter trial to fluid resuscitation in the with 6 percent HES 130/0.4 or Ringer's acetate (up to 33 mL per kilogram of ideal body weight per day).

The researchers found that, at 90 days following randomization, 201 of 398 patients assigned to HES 130/0.4 had died, compared to 172 of 400 patients assigned to Ringer's acetate (relative risk [RR], 1.17; 95 percent confidence interval [CI], 1.01 to 1.36), and one patient in each group had end-stage . In the HES 130/0.4 group, 87 patients (22 percent) were treated with renal replacement therapy in the 90-day period, compared to 65 patients (16 percent) in the Ringer's acetate group (RR, 1.35; 95 percent CI, 1.01 to 1.80), and 38 and 25 patients, respectively, had severe bleeding (RR, 1.52; 95 percent CI, 0.94 to 2.48).

"Patients with severe assigned to fluid resuscitation with HES 130/0.4 had an increased risk of death at day 90 and were more likely to require renal-replacement therapy, as compared with those receiving Ringer's acetate," the authors write.

Perner disclosed receiving grant support from Fresenius Kabi.

Explore further: Combination antibiotic treatment does not result in less organ failure in adults with severe sepsis

More information: Abstract
Full Text

Related Stories

Combination antibiotic treatment does not result in less organ failure in adults with severe sepsis

May 21, 2012
Frank M. Brunkhorst, M.D., of Friedrich-Schiller University, Jena, Germany, and colleagues conducted a study to compare the effect of the antibiotics moxifloxacin and meropenem with the effect of meropenem monotherapy on ...

BUSM: Severe sepsis, new-onset AF associated with increased risk of hospital stroke, death

November 13, 2011
A recent study led by researchers at Boston University School of Medicine (BUSM) shows an increased risk of stroke and mortality among patients diagnosed with severe sepsis and new-onset atrial fibrillation (AF) during hospitalization.

Arthritis patients taking newer treatments do not have an overall increased cancer risk

May 27, 2011
Only three percent (n=181) of patients in the study cohort receiving anti-tumour necrosis factor agents (anti-TNFs) for treatment of their arthritis developed a first cancer within nine years and overall risk was not dependent ...

Continued treatment for lupus may boost survival of those patients with end-stage kidney disease

September 20, 2011
Researchers at Albert Einstein College of Medicine of Yeshiva University have shown that close supervision by rheumatologists and the use of immunosuppressant drugs improve the survival of lupus patients with end-stage kidney ...

Cancer risk up in bilateral retinoblastoma survivors

February 23, 2012
(HealthDay) -- For survivors of bilateral retinoblastoma (Rb), family history is associated with an increased risk of second cancers (SCs), especially melanoma, according to a study published online Feb. 21 in the Journal ...

Recommended for you

New study offers insights on genetic indicators of COPD risk

January 16, 2018
Researchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who have low, but stable, lung function early in life, and those who are particularly at risk ...

Previous influenza virus exposures enhance susceptibility in another influenza pandemic

January 16, 2018
While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, Canadian researchers are calling for more attention to exceptions to that rule.

Don't hold your nose and close your mouth when you sneeze, doctors warn

January 15, 2018
Pinching your nose while clamping your mouth shut to contain a forceful sneeze isn't a good idea, warn doctors in the journal BMJ Case Reports.

New antifungal provides hope in fight against superbugs

January 12, 2018
Microscopic yeast have been wreaking havoc in hospitals around the world—creeping into catheters, ventilator tubes, and IV lines—and causing deadly invasive infection. One culprit species, Candida auris, is resistant ...

Dengue takes low and slow approach to replication

January 11, 2018
A new study reveals how dengue virus manages to reproduce itself in an infected person without triggering the body's normal defenses. Duke researchers report that dengue pulls off this hoax by co-opting a specialized structure ...

Different strains of same bacteria trigger widely varying immune responses

January 11, 2018
Genetic differences between different strains of the same pathogenic bacterial species appear to result in widely varying immune system responses, according to new research published in PLOS Pathogens.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.